EP1171116A4 - Methode de prevention ou reduction d'incidents cardio-vasculaires associes a une intervention coronarienne - Google Patents

Methode de prevention ou reduction d'incidents cardio-vasculaires associes a une intervention coronarienne

Info

Publication number
EP1171116A4
EP1171116A4 EP00904640A EP00904640A EP1171116A4 EP 1171116 A4 EP1171116 A4 EP 1171116A4 EP 00904640 A EP00904640 A EP 00904640A EP 00904640 A EP00904640 A EP 00904640A EP 1171116 A4 EP1171116 A4 EP 1171116A4
Authority
EP
European Patent Office
Prior art keywords
cariovascular
prevention
reduction
events associated
coronary intervention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00904640A
Other languages
German (de)
English (en)
Other versions
EP1171116A1 (fr
Inventor
Jeffrey R Granett
Neil H Shusterman
Prichard David C U
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP1171116A1 publication Critical patent/EP1171116A1/fr
Publication of EP1171116A4 publication Critical patent/EP1171116A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP00904640A 1999-02-03 2000-02-02 Methode de prevention ou reduction d'incidents cardio-vasculaires associes a une intervention coronarienne Withdrawn EP1171116A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11846299P 1999-02-03 1999-02-03
US118462P 1999-02-03
PCT/US2000/002622 WO2000045811A1 (fr) 1999-02-03 2000-02-02 Methode de prevention ou reduction d'incidents cardio-vasculaires associes a une intervention coronarienne

Publications (2)

Publication Number Publication Date
EP1171116A1 EP1171116A1 (fr) 2002-01-16
EP1171116A4 true EP1171116A4 (fr) 2004-11-17

Family

ID=22378750

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00904640A Withdrawn EP1171116A4 (fr) 1999-02-03 2000-02-02 Methode de prevention ou reduction d'incidents cardio-vasculaires associes a une intervention coronarienne

Country Status (17)

Country Link
EP (1) EP1171116A4 (fr)
JP (1) JP2002536327A (fr)
KR (1) KR20010101934A (fr)
CN (1) CN1345237A (fr)
AU (1) AU2636600A (fr)
BR (1) BR0007921A (fr)
CA (1) CA2361581A1 (fr)
CO (1) CO5150206A1 (fr)
HK (1) HK1045104A1 (fr)
HU (1) HUP0200129A3 (fr)
IL (1) IL144721A0 (fr)
MX (1) MXPA01007835A (fr)
NO (1) NO20013788L (fr)
PL (1) PL351397A1 (fr)
TR (1) TR200102245T2 (fr)
WO (1) WO2000045811A1 (fr)
ZA (1) ZA200106353B (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998029104A2 (fr) * 1996-12-30 1998-07-09 Kissei Pharmaceutical Co., Ltd. Utilisation d'acide 2-(3,4-dimethoxycinnamoyl)aminobenzoique dans la fabrication d'un medicament destine au traitement ou a la prevention de la restenose
EP0855387A1 (fr) * 1995-09-07 1998-07-29 Kissei Pharmaceutical Co., Ltd. Derives de 2-acylaminobenzamide, preventif et remede contre des maladies causees par une surmultiplication des cellules vasculaires de l'intima

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2617407B2 (ja) * 1992-09-14 1997-06-04 キッセイ薬品工業株式会社 血管内膜細胞過剰増殖疾患の予防および治療剤
CA2153553A1 (fr) * 1994-07-13 1996-01-14 Hidekazu Suzuki Emulsion stable de lipides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0855387A1 (fr) * 1995-09-07 1998-07-29 Kissei Pharmaceutical Co., Ltd. Derives de 2-acylaminobenzamide, preventif et remede contre des maladies causees par une surmultiplication des cellules vasculaires de l'intima
WO1998029104A2 (fr) * 1996-12-30 1998-07-09 Kissei Pharmaceutical Co., Ltd. Utilisation d'acide 2-(3,4-dimethoxycinnamoyl)aminobenzoique dans la fabrication d'un medicament destine au traitement ou a la prevention de la restenose

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0045811A1 *

Also Published As

Publication number Publication date
PL351397A1 (en) 2003-04-07
CA2361581A1 (fr) 2000-08-10
JP2002536327A (ja) 2002-10-29
MXPA01007835A (es) 2002-04-24
HUP0200129A2 (hu) 2002-05-29
IL144721A0 (en) 2002-06-30
CN1345237A (zh) 2002-04-17
BR0007921A (pt) 2002-09-10
ZA200106353B (en) 2002-08-02
HK1045104A1 (zh) 2002-11-15
NO20013788L (no) 2001-09-28
WO2000045811A1 (fr) 2000-08-10
TR200102245T2 (tr) 2002-05-21
AU2636600A (en) 2000-08-25
KR20010101934A (ko) 2001-11-15
NO20013788D0 (no) 2001-08-02
HUP0200129A3 (en) 2003-06-30
EP1171116A1 (fr) 2002-01-16
CO5150206A1 (es) 2002-04-29

Similar Documents

Publication Publication Date Title
NZ514350A (en) Compositions and methods for effecting the levels of cholesterol
GB2352377B (en) Noise suppression method
HUP0203746A3 (en) Novel composition and method for stabilizing the same
AU5294100A (en) Method and compositions for treating the inflammatory response
HUP0104976A2 (en) Method for the preparation of 5-cyanophthalide
EP0669362A3 (fr) Procédé de préparation de polytitanosiloxanes solubles dans des solvants organiques.
HK1052702A1 (en) Method for the preparation of 5-carboxyphthalide.
EP1239855A4 (fr) Procede de prevention et/ou de traitement de l'atherosclerose
IL148518A (en) Optoelectronic assembly and method for fabricatingthe same
IL128613A0 (en) Method for inhibiting the expression of fas
HK1048889A1 (zh) 部件及其製造方法
ZA200107523B (en) Method for improving the stability of stored and/or light-sensitive therapeutic systems or component thereof.
AU2001243248A1 (en) Method for the prevention or reduction of vascular access dysfunction
PL351397A1 (en) Method for the prevention or reduction of cariovascular events associated with coronary intervention
ZA200110474B (en) Method and device for the continuous of NaAlCl4 or NaFeCl4.
PL349926A1 (en) Method for the prevention or reduction of cardiovascular events associated with coronary intervention
AU2001275414A1 (en) Method for the prevention or reduction of cardiovascular events associated with coronary intervention
GB9928570D0 (en) Nut lock
EP1217232A4 (fr) Ecrou de blocage
GB0006745D0 (en) Stud for partititioning or the like
TW371925U (en) Structure of the caster
TW437347U (en) Shelving for suspension from rafters or the like
ZA200007580B (en) Materials and methods for prevention or reduction of the severity of heartwater.
TW376949U (en) Improved structure for the venetial blinds of combination type
PL333864A1 (en) Method of controlling the operation of static compensator system

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010823

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI PAYMENT 20010823

A4 Supplementary search report drawn up and despatched

Effective date: 20041005

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20041223

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1045104

Country of ref document: HK